Victor Ho

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

A Novel Polymersome Nanocarrier Promotes Anti-Tumour Immunity by Improved Priming of CD8 + T Cells.

A Novel Polymersome Nanocarrier Promotes Anti-Tumour Immunity by Improved Priming of CD8 + T Cells.

Journal: Immunology
Published: September 10, 2024

Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Erratum: Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Journal: NPJ vaccines
Published: November 01, 2019

Temporal release of a three-component protein subunit vaccine from polymer multilayers.

Temporal release of a three-component protein subunit vaccine from polymer multilayers.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 06, 2019

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.

Journal: Frontiers in immunology
Published: March 27, 2019

RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity.

RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing Cytotoxicity.

Journal: Journal of virology
Published: January 25, 2019

Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Journal: NPJ vaccines
Published: March 08, 2018

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression.

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression.

Journal: Oncotarget
Published: April 01, 2015

Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium.

Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium.

Journal: PloS one
Published: July 14, 2014

Expression analysis of rare cellular subsets: direct RT-PCR on limited cell numbers obtained by FACS or soft agar assays.

Expression analysis of rare cellular subsets: direct RT-PCR on limited cell numbers obtained by FACS or soft agar assays.

Journal: BioTechniques
Published: December 22, 2012

Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.

Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.

Journal: Breast cancer research : BCR
Published: November 07, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026